Predictive Values of Presepsin Levels in ASciteS in Patients With Chronic Liver Failure
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorCarol Davila University of Medicine and Pharmacy
About this trial
The investigators aim to study the predictive value of presepsin in ascites in newly admitted patients with chronic liver failure.
Eligibility criteria
Qualifiers
patient with ascites and chronic liver failure
no contraindications and technical possibility to perform diagnostic paracentesis
age above 18 years old
informed consent
Disqualifiers
contraindications to paracentesis or technical impossibility to perform paracentesis
absence of informed consent
Trial design
Treatments tested in this trial
- Determination of presepsin levels in ascites
Treatment groups
30 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov